Also categorized in Business of Medicine:
The first U.S. trials in people put CRISPR to the test in 2019
x hide permanently

Remdesivir Priced at More Than $3,100 for a Course of Treatment

npr.org

Photo: ULRICH PERREY/POOL/AFP via Getty Images

npr.org

The drugmaker behind the experimental COVID-19 treatment remdesivir has announced how much it will charge for the drug, after months of speculation as the company tried to figure out how to balance profit and public health needs in the middle of a pandemic.

In the United States, Gilead Sciences will charge $520 per vial for patients with private insurance, with some government programs getting a lower price. With a double-dose the first day, that comes out to $3,120 for the five-day treatment course. For governments in developed countries outside ...